| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 0 | 3.655 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 0 | 8 | 3.660 | 17 |
| Total Expenses - EUR | - | - | - | - | 369 | 111 | 10 | 1.581 | 13.581 | 9.415 |
| Gross Profit/Loss - EUR | - | - | - | - | -369 | -111 | -10 | -1.573 | -9.921 | -9.398 |
| Net Profit/Loss - EUR | - | - | - | - | -369 | -111 | -10 | -1.573 | -9.957 | -9.398 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuromuscular S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 11.195 | 9.642 | 8.078 |
| Current Assets | - | - | - | - | 221 | 217 | 212 | 154 | 2.398 | 30.190 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 28.226 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 4 | 3 | 37 |
| Cash | - | - | - | - | 221 | 217 | 212 | 150 | 2.394 | 1.927 |
| Shareholders Funds | - | - | - | - | -327 | -431 | -432 | -2.006 | -11.958 | -21.289 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 548 | 648 | 644 | 13.355 | 23.997 | 59.557 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Neuromuscular S.r.l.